The effects of Ezetimibe on the LDL-Cholesterol particle number

Cardiovascular Drugs and Therapy

Volumn 18, Issue 4, 2004, Pages 327-328

  Al Shaer, Moutasim Homod ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

ATP III; case report; Cholesterol absorption inhibitors; Coronary artery disease; Ezetimibe; LDL; NMR; particle number; particle size; Zetia

Indexed keywords

EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MYALGIA; PARTICLE SIZE; PRIORITY JOURNAL;

AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; PARTICLE SIZE;

EID: 4544380961     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CARD.0000041253.85861.24     Document Type: Article

References (5)

1. van Heek M, Compton DS, Davis HR. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. European Journal of Pharmacology 2001;415:79-84.
2. LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation 1990;81:1721.
3. Sacks FM, Campos H. Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal, The Journal of Clinical Endocrinology & Metabolism 2003;88:4525-4532.
4. Lamarche B, Tchernof A, Moorjani S, et al. Small Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men: Prospective Results from the Quebec Cardiovascular Study. Circulation, 1997;95:69-75.
5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.